Elecsys® ProGRP
... , M., Parkin, D.M., Forman, D., Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide ... ., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and ...
Линейка продуктов для анализа методами ИГХ/ISH в диагностике рака м...
... HER2 Dual ISH assay is concordant to FISH and reproducible in determining HER2 gene status in invasive ... Francisco, California, USA. Paolini D, Rossoni R, Guardione D, Vrena V. Economical and organizational impact ... gene status in invasive breast carcinoma. Poster presented at the ASCO Breast Cancer Symposium; 2011 ... ; September 8-10: San Francisco, California, USA. Paolini D, Rossoni R, Guardione D, Vrena V. Economical and ...
Модульная система cobas u 601 и cobas u 701
... , D.-H. (2018). The efficient workflow to decrease the manual microscopic examination of urine ... 24(1), 89-104, 894. Cobbaert, C., Arslan, F. (2019). Automated urinalysis combining physicochemical ... Cho, E.-J., Ko, D.-H. (2018). The efficient workflow to decrease the manual microscopic examination of ... . Biochemia Medica 24(1), 89-104, 894. Cobbaert, C., Arslan, F. (2019). Automated urinalysis combining ...
Roche_magazine_number 5-v21.indd
... < D> – 2 400 тестов/час, модуль – 800 БХ тестов/час; ISE = ионселективный электрод; TDM ... Литература 1. Horowitz, G. L.; Zaman, Z.; Blanckaert, N.; Chan, D. W.; Dubois, J. A.; Golaz, O.; Mensi, N ... < D> – 2 400 тестов/час, модуль – 800 БХ тестов/час; ISE = ионселективный электрод; TDM ... Литература 1. Horowitz, G. L.; Zaman, Z.; Blanckaert, N.; Chan, D. W.; Dubois, J. A.; Golaz, O.; Mensi, N ...
Roche_magazine_number 8_30 nov 2017_press.indd
Roche_magazine_number 8_30 nov 2017_press.indd, https://diagnostics.roche.com/content/dam/diagnostics/ru/ru/DAM/promo/did_magazine/magazine_9.pdf, Roche_magazine_number 8_30 nov 2017_press.indd Пя...
Roche_magazine_number 8_30 nov 2017_v2.indd
... -890. 5. Huh W.K., Ault K.A., Chelmow D. et al. Use of primary high-risk human papillomavirus testing ... for cervical cancer screening: Interim clinical guidance. Gynecol Oncol. 2015;136:178-182. 6. Saslow D ... -890. 5. Huh W.K., Ault K.A., Chelmow D. et al. Use of primary high-risk human papillomavirus testing ... for cervical cancer screening: Interim clinical guidance. Gynecol Oncol. 2015;136:178-182. 6. Saslow D ...
https://diagnostics.roche.com/content/dam/diagnostics/ru/ru/DAM/pro...
... =4e043d03_14. Accessed April 15, 2020. 11 Wang, D. et al. (2020). JAMA. 10.1001/jama.2020.1585. 12 Huang, C. et ... : https://doi.org/10.1101/2020.03.18.20038059. 29 Amanat, F. et al. (2020). medRxiv. preprint doi:https ... =4e043d03_14. Accessed April 15, 2020. 11 Wang, D. et al. (2020). JAMA. 10.1001/jama.2020.1585. 12 Huang, C. et ... : https://doi.org/10.1101/2020.03.18.20038059. 29 Amanat, F. et al. (2020). medRxiv. preprint doi:https ...
https://diagnostics.roche.com/content/dam/diagnostics/ru/ru/DAM/pro...
... ) . . . . . . . . . .14 Многоцентровая оценка и характеристики теста Elecsys® Vitamin D Total ... 2003; 3: 243-254. 4. Adcock, D. Sample integrity and preanalytical variables. In: Olson J.D., Kitchen ... ) . . . . . . . . . .14 Многоцентровая оценка и характеристики теста Elecsys® Vitamin D Total ... 2003; 3: 243-254. 4. Adcock, D. Sample integrity and preanalytical variables. In: Olson J.D., Kitchen ...
VENTANA anti-ALK (D5F3) первичное кроличье моноклональное антитело
... ., Rebelo, M., Parkin, D.M., Forman, D., Bray, F. (2012). GLOBOCAN v1.0, Cancer Incidence and Mortality ... , R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F. (2012). GLOBOCAN v1.0 ...
cobas® HIV-1 Test
... Defic Syndr. 2001;56: 239-243. Damond F, et al. Evaluation of an upgraded version of the HIV-1 test for ... ) Специфичность 100% (односторонний 95% доверительный интервал: 99,5%) Определяемые субтипы ВИЧ-1 группы M (A– D ... , F–H, CRF01_AE, CRF02_AG), ВИЧ-1 группы O, ВИЧ-1 группы N Назначение Назначение IVD Тест cobas ...
